Douglass Hochstetler serves as lead counsel in patent infringement matters, especially in litigation arising under the Hatch-Waxman Act. Selected as one of The Best Lawyers in America© in Patent Law & Litigation; an “IP Star” by Managing Intellectual Property magazine, a “Super Lawyer” for 2017, and a “Leading Lawyer” in Intellectual Property Law by Illinois Leading Lawyers Network, he has represented generic drug companies in Hatch-Waxman matters for the last 20 years.
Prior to being a partner in a large law firm and IP boutique firm since 1990, Doug served as an associate at an IP boutique firm from 1985 to 1990, served in legal and business positions at a large chemical company from 1977 to 1985, and clerked for a Crystal City patent firm and the U.S. Department of Justice while in law school.
Abbott Laboratories v. Mylan Inc. (N.D. Ill) (lopinavir/ritonavir)
Abbott Laboratories v. Novartis Nutrition (N.D. Ill) (nutritional supplement)
AHP v. Upjohn Co. (D.N.J.) (canine vaccine)
AstraZeneca Pharmaceuticals LP v. Sandoz, Inc. (D.N.J. and Fed. Cir.) (quetiapine)
AstraZeneca LP v. Lek Pharmaceuticals (S.D.N.Y.) (omeprazole)
AstraZeneca Pharmaceuticals LP v. Lupin Pharmaceuticals (D.N.J.) (esomeprazole)
Cephalon, Inc. v. Sandoz, Inc. (D.N.J.) (modafinil)
Elan v. Corepharma (E.D.N.Y.) (metaxalone)
Endo Pharm. v. Perrigo Co. (D. Del.) (testosterone)
Forest Laboratories v. Lupin Pharmaceuticals (D. Del.) (memantine)
Forest Laboratories, LLC v. Lupin Ltd (D.N.J.) (memantine hydrochloride)
G.D. Searle LLC v. Lupin Pharmaceuticals, Inc. (E.D.Va. and Fed. Cir.) (celecoxib)
Jordan v. Isuzu Motors (N.D. Ill.) (automobile component)
LAB, SA v. Chemithon Corporation. (W.D. Wash.) (electrostatic precipitation equipment)
McNeil-PPC v. Procter & Gamble (D. Colo.) (sanitary products)
Orexo v. Mylan (D.N.J.) (zolpidem)
Organon Pharmaceuticals v. Geneva Pharmaceuticals (D.N.J.) (mirtazapine)
Oscar Mayer v. Sara Lee (W.D. Wisc.) (package design)
Otsuka Pharmaceutical Co., Ltd. v. Lupin Ltd. (D.N.J.) (aripiprazole)
Pfizer, Inc. v. Geneva Pharmaceuticals (D.N.J.) (gabapentin)
Pfizer, Inc. v. Sandoz, Inc. (D. Del.) (azithromycin)
Proctor & Gamble v. Kimberly-Clark (D.S.C.) (disposable diapers)
RCT v. Ben Venue Laboratories (D.N.J.) (cisplatin)
Sanofi v. Sandoz, Inc. (D.N.J. and Fed. Cir.) (oxaliplatin)
Schering-Plough v. Geneva Pharmaceuticals (D.N.J. and Fed. Cir.) (loratadine)
Sciele Pharma, Inc. v. Lupin Pharmaceuticals (D. Del. and Fed. Cir.) (metformin)
Sepracor, Inc. v. Lupin Pharmaceuticals (D.N.J.) (eszopiclone)
Shire LLC v. CorePharma, LLC (D.N.J.) (mixed amphetamine salts)
Shire Pharmaceuticals v. Mylan Inc. (S.D.N.Y.) (lanthanum carbonate)
Taro Pharmaceuticals v. Synerx Pharma, LLC (D.N.J.) (malathion lotion)
Teva Women’s Health v. Lupin Pharmaceuticals, Inc., et al. (D.N.J.) (oral contraceptives)
Transco Prods. v. PCI (Fed. Cir.) (nuclear reactor insulation)
UCB, Inc. v. CorePharma, LLC (D.N.J.) (methylphenidate)
Unigen Pharmaceuticals v. Perrigo Company, et al. (W.D. Wash.) (antioxidant product)
United States Gypsum v. National Gypsum (N.D. Ill. and Fed. Cir.) (lightweight joint compound)
Warner Chilcott v. Lupin Pharmaceuticals (D. Del.) (oral contraceptives)
The Best Lawyers in America© (Woodward/White, Inc.), Patent Law & Intellectual Property–Litigation, 2015-2017.
Listed in Illinois Super Lawyers, 2017.
Selected as a 2014 “IP Star” by Managing Intellectual Property magazine.
Leading Lawyer–Intellectual Property Law, Illinois Leading Lawyers Network.